A new study conducted by Chinese scientists revealed the mechanism behind bacterial treatment for cancer using a genetically modified bacterial dynasty, developing the next generation of cancer treatments.
The Xinhua News Agency reported that exploring the use of anti -tumor bacteria in the treatment of cancer dates back to the 1960s, as the clinical application for the treatment of cancer -based cancer faced great challenges in terms of safety and effectiveness.
The recent developments in artificial biology enabled the development of new anti -tumor bacteria, creating new ways for immunotherapy research.
The researchers have modified a diluted strain of bacteria, called “designed bacteria 1” (DB1), which survived and reproduces efficiently in the tumor tissue while it is disinfected in natural tissues, which has a remarkable effect on “targeting the tumor” in addition to the effect of “cleansing the tumor”.
The results of the study are light, on a decisive mechanism that has not been resolved before in the treatment of cancer with bacteria. This mechanism does not only provide valuable visions, but also act as a guideline of the design of genetically modified bacteria, which enhances safety and effectiveness.
The researchers proved the health of treatment in various animal models, and the results showed that these genetically modified bacteria prevent the growth, repetition and spread of multiple types of tumors.
The research is currently progressing towards clinical trials, and will provide a scientific basis for formulating personal treatment plans in the future.
